序号 |
标题 |
次数 |
作者 |
发布时间 |
81406 |
3-(3,5-二甲基吡唑基)-6-肼基-1,2,4,5-四嗪(DAHTz)与3,5-二硝基水杨酸盐(DNSA)的结合体(DAHTz·DNSA·H2O) |
119 |
WYQ |
2024-12-03 |
81407 |
3,6-二(2H-5-四唑基)-1,2,4,5-四嗪(BTT) |
153 |
WYQ |
2024-12-03 |
81408 |
1,1′-二甲基-5,5′-偶氮四嗪(DMATZ) |
79 |
WYQ |
2024-12-03 |
81409 |
稀土纳米颗粒NaGdF4修饰四嗪(NaGdF4-Tz) |
167 |
WYQ |
2024-12-03 |
81410 |
alkynyl-FA,炔基修饰叶酸 |
100 |
wyh |
2024-12-03 |
81411 |
6-(3,5-二甲基吡唑)-N-(1H-1,2,4-三唑)-1,2,4,5-四嗪-3-氨(DPTTz) |
118 |
WYQ |
2024-12-03 |
81412 |
6-(1H-吡唑)-N-(1H-1,2,4-三唑)-1,2,4,5-四嗪-3-氨(PTTz) |
118 |
WYQ |
2024-12-03 |
81413 |
白蛋白靶向的布洛芬-Gd-DOTA,Ibu-Gd-BSA NPs |
116 |
wyh |
2024-12-03 |
81414 |
Cy5.5-NKL,Cy5.5标记NKL新型探针 |
87 |
wyh |
2024-12-03 |
81415 |
DOTA修饰司帕沙星 , DOTA-SPFX |
113 |
wyh |
2024-12-03 |
81416 |
DOTA-PEG-GA, DOTA-聚乙二醇-GA |
78 |
wyh |
2024-12-03 |
81417 |
3,6-双(3,5-二甲基吡唑)-1,2,4,5-四嗪(BT) |
84 |
WYQ |
2024-12-03 |
81418 |
钆(Gd)金属配合物(Gd-DOTA) |
130 |
wyh |
2024-12-03 |
81419 |
3,6-双硝基胍基-1,2,4,5-四嗪双氨基胍盐(AG2DNGTz) |
100 |
WYQ |
2024-12-03 |
81420 |
3-(3,5-二甲基吡唑基)-6-苯基亚甲基腙-1,2,4,5-四嗪(DAHBTz) |
79 |
WYQ |
2024-12-03 |
81421 |
DOTA-Cy5.5-PS,DOTA-Cy5.5-聚苯乙烯 |
90 |
wyh |
2024-12-03 |
81422 |
3-(3,5-二甲基吡唑基)-6-肼基-1,2,4,5-四嗪(DAHTz) |
81 |
WYQ |
2024-12-03 |
81423 |
NH2-PEG-DOTA-PEG-NH2,氨基-聚乙二醇-DOTA-聚乙二醇-氨基 |
103 |
wyh |
2024-12-03 |
81424 |
P(VDF-TrFE)@DOTA-Gd@RGD ,复合压电纳米粒子 |
113 |
wyh |
2024-12-03 |
81425 |
双吡啶基配体3,6-二(4-吡啶基)-1,2,4,5-四嗪(DPT) |
139 |
WYQ |
2024-12-03 |
81426 |
四嗪-聚乙二醇-N-羟基琥珀酰亚胺酯偶联1,2-二硬脂酰基-sn-甘油基-3-磷酸乙醇胺-N-[氨基(聚乙二醇)-2000](DSPE-PEG2k-NH2) |
101 |
WYQ |
2024-12-03 |
81427 |
修饰Tetrazine的脂质分子(DSPE-PEG2k-PEG5-Tetrazine) |
118 |
WYQ |
2024-12-03 |
81428 |
3,6-双硝基胍基-1,2,4,5-四嗪双胍盐(G2DNGTz) |
103 |
WYQ |
2024-12-03 |
81429 |
3,6-双(3-硝基-1,2,4-噁二唑-5-胍基)-1,2,4,5-四嗪(NOG2Tz) |
126 |
WYQ |
2024-12-03 |
81430 |
(68)Ga-NOTA-Tz)结合了放射性同位素^(68)Ga |
102 |
WYQ |
2024-12-03 |
81431 |
HPMADOTAGd,DOTA偶联多聚HPMAGd磁共振成像探针 |
115 |
wyh |
2024-12-03 |
81432 |
1,2,3,4-四嗪-1,3-二氧化物(Benzo-1,2,3,4-tetrazine-1,3-dioxide) |
152 |
WYQ |
2024-12-03 |
81433 |
DOTAtEBTMTP1,DOTA修饰tEBTMTP1化合物 |
84 |
wyh |
2024-12-03 |
81434 |
3,6二氨基-1,2,4,5-四嗪-1,4-二氧化物(DATZO2) |
104 |
WYQ |
2024-12-03 |
81435 |
DOTA-VEGFDEE ,DOTA偶联突变体VEGFDEE |
85 |
wyh |
2024-12-03 |
81436 |
3,6-双(3,5-二甲基-吡唑-1-酰基)-1,2,4-四嗪(BT) |
95 |
WYQ |
2024-12-03 |
81437 |
DOTA-Cy5.5-NP,聚合物修饰上双功能螯合剂DOTA和近红外染料Cy5.5 |
103 |
wyh |
2024-12-03 |
81438 |
1,2,3,4-四嗪-1,3-二氧化物;Benzo-1,2,3,4-tetrazine-1,3-dioxide |
117 |
WYQ |
2024-12-03 |
81439 |
DOTA-dPEG2-R954,DOTA偶联R954衍生物 |
98 |
wyh |
2024-12-03 |
81440 |
3,6二氨基-1,2,4,5-四嗪-1,4-二氧化物(DATZO2);3,6-Diamino-1,2,4,5-tetrazine-1,4-dioxide |
97 |
WYQ |
2024-12-03 |
81441 |
3,6-双(3,5-二甲基-吡唑-1-酰基)-1,2,4-四嗪(BT);3,6-bis ( 3,5-dimethyl-pyrazol-1-oyl)-1,2,4,5-tetrazine |
114 |
WYQ |
2024-12-03 |
81442 |
3,6-双胍基-1,2,4,5-四嗪(DGTZ) |
138 |
WYQ |
2024-12-03 |
81443 |
氨基酸衍生物L-4-四嗪-苯丙氨酸 |
128 |
WYQ |
2024-12-03 |
81444 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
95 |
WYQ |
2024-12-03 |
81445 |
3-氨基-6-(3,5-二甲基吡唑基-1-基)-1,2,4-三唑[4,3-b]-1,2,4,5-四嗪(ADTTz) |
102 |
WYQ |
2024-12-03 |
81446 |
3-[(对甲氧基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DPMHT) |
118 |
WYQ |
2024-12-03 |
81447 |
3-[(3-甲氧基-4-羟基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DMPT) |
187 |
WYQ |
2024-12-03 |
81448 |
[Tc-99m]HYNIC-PEG(11)-Tz;[Tc-99m]标记联肼尼克酰胺多肽--PEG11-四嗪 |
93 |
WYQ |
2024-12-03 |
81449 |
maleimide-PEG-NHS ,马来酰亚胺-聚乙二醇-活性酯 |
88 |
wyh |
2024-12-03 |
81450 |
氨基聚乙二醇功能化的金纳米粒,AuNP-PEG-NH |
139 |
wyh |
2024-12-03 |